Epigenomics, a molecular diagnostics company developing tests based on DNAmethylation, is developing a test for the methylation of a single gene, PITX2, that can predict recurrence of prostate cancer after radical surgery. This new test is not yet available but it looks worth watching out for. The same company is developing a blood [...]
Read The Full Article:
http://www.drilltools.org/260
Add to del.icio.us
Digg this
Post to Furl
Add to reddit
Add to myYahoo!
Powered by blogdig.net